Mylan’s Biosimilars Close In On $1bn Milestone

Firm Reveals Annual Sales Total From Biosimilars Business

 
• By Dave Wallace

Mylan says it is closing in on $1bn in cumulative sales of its biosimilars, also disclosing its annual turnover figure from biosimilars as it reported its second-quarter results.

Billion_Dollar
Mylan’s cumulative sales of biosimilars are approaching $1bn in total • Source: Shutterstock

More from Biosimilars

More from Products